InspireMD Past Earnings Performance
Past criteria checks 0/6
InspireMD's earnings have been declining at an average annual rate of -19.7%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 13.4% per year.
Key information
-19.7%
Earnings growth rate
85.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 13.4% |
Return on equity | -50.4% |
Net Margin | -321.0% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Here's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn Situation
Jan 11We Think InspireMD (NASDAQ:NSPR) Needs To Drive Business Growth Carefully
Jan 27We're Keeping An Eye On InspireMD's (NASDAQ:NSPR) Cash Burn Rate
Oct 05InspireMD: Revolutionizing The Field Of Vascular Stenting
Sep 20Trade Alert: Gary Roubin At InspireMD, Inc. (NYSEMKT:NSPR), Has Just Spent US$150k Buying 52% More Shares
Feb 11Revenue & Expenses BreakdownBeta
How InspireMD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 6 | -20 | 15 | 8 |
30 Sep 23 | 5 | -19 | 14 | 8 |
30 Jun 23 | 5 | -19 | 13 | 8 |
31 Mar 23 | 5 | -18 | 12 | 8 |
31 Dec 22 | 5 | -18 | 12 | 8 |
30 Sep 22 | 6 | -18 | 12 | 7 |
30 Jun 22 | 5 | -17 | 11 | 7 |
31 Mar 22 | 5 | -16 | 11 | 6 |
31 Dec 21 | 4 | -15 | 10 | 5 |
30 Sep 21 | 3 | -15 | 10 | 4 |
30 Jun 21 | 3 | -13 | 9 | 3 |
31 Mar 21 | 2 | -12 | 9 | 3 |
31 Dec 20 | 2 | -11 | 8 | 2 |
30 Sep 20 | 3 | -9 | 8 | 2 |
30 Jun 20 | 3 | -9 | 8 | 2 |
31 Mar 20 | 4 | -9 | 7 | 2 |
31 Dec 19 | 4 | -10 | 8 | 3 |
30 Sep 19 | 4 | -10 | 7 | 3 |
30 Jun 19 | 3 | -10 | 7 | 3 |
31 Mar 19 | 3 | -8 | 7 | 2 |
31 Dec 18 | 4 | -8 | 7 | 2 |
30 Sep 18 | 4 | -11 | 7 | 1 |
30 Jun 18 | 4 | -11 | 7 | 1 |
31 Mar 18 | 3 | -12 | 7 | 1 |
31 Dec 17 | 3 | -13 | 8 | 1 |
30 Sep 17 | 2 | -10 | 8 | 1 |
30 Jun 17 | 2 | -10 | 7 | 1 |
31 Mar 17 | 2 | -9 | 7 | 1 |
31 Dec 16 | 2 | -8 | 6 | 1 |
30 Sep 16 | 2 | -9 | 6 | 2 |
30 Jun 16 | 2 | -11 | 7 | 2 |
31 Mar 16 | 2 | -13 | 8 | 3 |
31 Dec 15 | 2 | -16 | 10 | 4 |
30 Sep 15 | 3 | -18 | 11 | 4 |
30 Jun 15 | 2 | -21 | 13 | 6 |
31 Mar 15 | 2 | -24 | 15 | 8 |
31 Dec 14 | 3 | -25 | 16 | 9 |
30 Sep 14 | 4 | -26 | 16 | 9 |
30 Jun 14 | 5 | -23 | 15 | 8 |
31 Mar 14 | 6 | -30 | 15 | 7 |
31 Dec 13 | 6 | -29 | 14 | 5 |
30 Sep 13 | 6 | -26 | 13 | 6 |
30 Jun 13 | 5 | -29 | 12 | 5 |
Quality Earnings: NSPR is currently unprofitable.
Growing Profit Margin: NSPR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NSPR is unprofitable, and losses have increased over the past 5 years at a rate of 19.7% per year.
Accelerating Growth: Unable to compare NSPR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NSPR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: NSPR has a negative Return on Equity (-50.42%), as it is currently unprofitable.